Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2017-01-03 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于召开2017年第一次临时股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2017 first extraordinary general meeting (临时股东大会) of Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It includes information about the meeting date, voting procedures (including cumulative voting for board and supervisory board elections), registration methods, and proxy forms. The content focuses on the organization and conduct of a shareholders' meeting, specifically an extraordinary general meeting, rather than the results of the meeting or any financial report. There is no indication that this is a report of voting results or a proxy solicitation document. It is a meeting notice with detailed instructions and agenda items for shareholders. Therefore, the document fits best into the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings, including notices of meetings.
2017-01-03 Chinese
关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement (846 characters) regarding changes in shareholder equity, specifically an increase in shareholding by certain entities. It mentions that the change does not trigger a takeover offer and details the shareholding percentages. The document references compliance with securities laws and disclosure obligations but does not contain financial statements or detailed financial data. It is not a full report but a notification about shareholding changes. This fits the definition of a Major Shareholding Notification (MRQ).
2016-12-30 Chinese
关于监事会换届选举的提示性公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement regarding the supervisory board (监事会) re-election process for Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It includes information about the composition of the new supervisory board, election methods, nomination procedures, qualifications for candidates, and required documentation. The content focuses on governance and procedural details related to board member elections rather than financial results, audit opinions, or shareholder voting outcomes. It is not a full annual report, audit report, or earnings release. It is also not a voting result announcement since it does not provide final vote outcomes but rather the process and candidate nomination details. This type of document fits best under Board/Management Information (MANG), as it announces changes and procedures related to the company's supervisory board members.
2016-12-23 Chinese
关于董事会换届选举的提示性公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement regarding the upcoming board of directors election for Jiangsu Sihuan Bio Co., Ltd. It outlines the procedures, qualifications, nomination process, and other relevant details for the board re-election. There is no financial data, earnings information, or audit content. The focus is on management and board composition changes. The document is not a report itself but an official announcement about the board election process and related governance matters. Therefore, it fits best under the category of Board/Management Information (MANG). The document length is 4485 characters, which is consistent with a detailed announcement rather than a full report.
2016-12-23 Chinese
2016年第一次临时股东大会的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the legality and procedural compliance of a company's 2016 first extraordinary general meeting (EGM). It discusses the convening, voting procedures, attendance, and validity of the resolutions passed at the meeting. It does not contain financial statements or results but focuses on the legal aspects of the shareholders' meeting. This type of document is typically classified as a Regulatory Filing (RNS) because it is a legal opinion related to a shareholder meeting and does not fit into categories like AGM Information (which would be presentations/materials) or Declaration of Voting Results (which would be the official vote results announcement). The document length is short (2815 characters) and is a standalone legal opinion, not a report or announcement of a report publication. Therefore, the best classification is Regulatory Filings (RNS).
2016-12-19 Chinese
2016年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2016 first extraordinary general meeting (临时股东大会) of Jiangsu Sihuan Bioengineering Co., Ltd. It details the meeting date, attendance, voting results on specific proposals, and includes a legal opinion on the validity of the meeting and resolutions. There is no financial data or report content, only the official voting results and meeting procedural information. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (2155 characters) and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2016-12-19 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.